NCT00003280View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

Trial Locations (10)

4500

Burgerspital, Solothurn, Solothurn

5001

Kantonspital Aarau, Aarau

8063

City Hospital Triemli, Zurich

CH 4051

Office of Walter Weber-Stadelman, Basel

CH-4031

University Hospital, Basel

CH-6500

Ospedale San Giovanni, Bellinzona

CH-3010

Inselspital, Bern, Bern

CH-1211

Hopital Cantonal Universitaire de Geneva, Geneva

CH-6900

Istituto Oncologico della Svizzera Italiana, Lugano

CH-8008

Klinik Hirslanden, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00003280 - Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma | Biotech Hunter | Biotech Hunter